RESUMEN
Aedes mosquitoes are important vectors of re-emerging diseases in developing countries, and increasing exposure to Aedes in the developed world is currently a source of concern. Given the limitations of current entomologic methods, there is a need for a new effective way for evaluating Aedes exposure. Our objective was to evaluate specific antibody responses to Aedes aegypti saliva as a biomarker for vector exposure in a dengue-endemic urban area. IgG responses to saliva were strong in young children and steadily waned with age. Specific IgG levels were significantly higher in persons living in sites with higher Ae. aegypti density, as measured by using entomologic parameters. Logistic regression showed a significant correlation between IgG to saliva and exposure level, independently of either age or sex. These results suggest that antibody responses to saliva could be used to monitor human exposure to Aedes bites.
Asunto(s)
Formación de Anticuerpos/inmunología , Biomarcadores/sangre , Mordeduras y Picaduras/diagnóstico , Dengue/epidemiología , Dengue/transmisión , Adolescente , Adulto , Aedes , Animales , Bolivia/epidemiología , Análisis por Conglomerados , Países en Desarrollo , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Insectos Vectores/inmunología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Saliva/inmunología , Población Urbana , Adulto JovenRESUMEN
Yellow fever (YF) is a serious public health problem in Bolivia since at least the 19th century. Surprisingly, very limited information has been made available to date regarding the genetic characterisation and epidemiology of Bolivian YF virus (YFV) strains. Here, we conducted the genetic characterization of 12 human isolates of YFV collected in Bolivia between 1999 and 2008, by sequencing and analysis of two regions of the viral genome: a fragment encoding structural proteins "PrM" (premembrane and envelope) and a distal region "EMF," spanning the end of the virus genome. Our study reveals a high genetic diversity of YFV strains circulating in Bolivia during the last decade: we identified not only "Peruvian-like" genotype II viruses (related to previously characterized Bolivian strains), but also, for the fist time, "Brazilian-like" genotype I viruses. During the complete period of the study, only cases of "jungle" YF were detected (i.e., circulation of YFV via a sylvatic cycle) with no cluster of urban cases. However, the very significant spread of the Aedes aegypti mosquito across Bolivian cities threatens the country with the reappearance of an urban YFV transmission cycle and thus is required a sustained epidemiological surveillance.
Asunto(s)
Aedes/virología , Insectos Vectores/virología , Fiebre Amarilla/epidemiología , Virus de la Fiebre Amarilla/genética , Adulto , Animales , Evolución Biológica , Bolivia/epidemiología , Femenino , Variación Genética , Genotipo , Humanos , Masculino , Epidemiología Molecular , Filogenia , Salud Pública , ARN Viral/genética , Análisis de Secuencia de ADN , Proteínas del Envoltorio Viral/genética , Proteínas Virales/genética , Fiebre Amarilla/transmisión , Fiebre Amarilla/virología , Virus de la Fiebre Amarilla/aislamiento & purificación , Adulto JovenRESUMEN
Dengue fever was first recognized in Bolivia in 1931. However, very limited information was available to date regarding the genetic characterization and epidemiology of Bolivian dengue virus strains. Here, we performed genetic characterization of the full-length envelope gene of 64 Bolivian isolates from 1998 to 2008 and investigated their origin and evolution to determine whether strains circulated simultaneously or alternatively, and whether or not multiple introductions of distinct viral variants had occurred during the period studied. We determined that, during the last decade, closely related viruses circulated during several consecutive years (5, 6, and 6 years for DENV-1, DENV-2, and DENV-3, respectively) and the co-circulation of two or even three serotypes was observed. Emergence of new variants (distinct from those identified during the previous episodes) was identified in the case of DENV-1 (2007 outbreak) and DENV-2 (2001 outbreak). In all cases, it is likely that the viruses originated from neighboring countries.